{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T19:34:22Z","timestamp":1761766462632,"version":"3.37.3"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,9]],"date-time":"2018-11-09T00:00:00Z","timestamp":1541721600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,11,9]],"date-time":"2018-11-09T00:00:00Z","timestamp":1541721600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007123","name":"Stanley Medical Research Institute","doi-asserted-by":"publisher","award":["07R-1712","07R-1712"],"award-info":[{"award-number":["07R-1712","07R-1712"]}],"id":[{"id":"10.13039\/100007123","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health &amp; Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["MH63480"],"award-info":[{"award-number":["MH63480"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Acyclovir (ACV) is an effective antiviral agent for treating lytic Herpes Simplex virus, type 1 (HSV-1) infections, and it has dramatically reduced the mortality rate of herpes simplex encephalitis. However, HSV-1 resistance to ACV and its derivatives is being increasingly documented, particularly among immunocompromised individuals. The burgeoning drug resistance compels the search for a new generation of more efficacious anti-herpetic drugs. We have previously shown that trans-dihydrolycoricidine (R430), a lycorane-type alkaloid derivative, effectively inhibits HSV-1 infections in cultured cells. We now report that R430 also inhibits ACV-resistant HSV-1 strains, accompanied by global inhibition of viral gene transcription and enrichment of H3K27me3 methylation on viral gene promoters. Furthermore, we demonstrate that R430 prevents HSV-1 reactivation from latency in an <jats:italic>ex vivo<\/jats:italic> rodent model. Finally, among a panel of DNA viruses and RNA viruses, R430 inhibited Zika virus with high therapeutic index. Its therapeutic index is comparable to standard antiviral drugs, though it has greater toxicity in non-neuronal cells than in neuronal cells. Synthesis of additional derivatives could enable more efficacious antivirals and the identification of active pharmacophores.<\/jats:p>","DOI":"10.1038\/s41598-018-33904-y","type":"journal-article","created":{"date-parts":[[2018,11,5]],"date-time":"2018-11-05T16:52:27Z","timestamp":1541436747000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["R430: A potent inhibitor of DNA and RNA viruses"],"prefix":"10.1038","volume":"8","author":[{"given":"Leonardo","family":"D\u2019Aiuto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7123-7588","authenticated-orcid":false,"given":"James","family":"McNulty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroll","family":"Hartline","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Demers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raj","family":"Kalkeri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel","family":"Wood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lora","family":"McClain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ansuman","family":"Chattopadhyay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Zhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Naciri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Yolken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kodavali","family":"Chowdari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Zepeda-Velazquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chanti Babu","family":"Dokuburra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernesto","family":"Marques","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger","family":"Ptak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Kinchington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Watkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Prichard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5935-8494","authenticated-orcid":false,"given":"David","family":"Bloom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8485-5927","authenticated-orcid":false,"given":"Vishwajit","family":"Nimgaonkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,11,9]]},"reference":[{"key":"33904_CR1","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/S1474-4422(07)70267-3","volume":"6","author":"I Steiner","year":"2007","unstructured":"Steiner, I., Kennedy, P. G. & Pachner, A. R. The neurotropic herpes viruses: herpes simplex and varicella-zoster. Lancet Neurol 6, 1015\u20131028 (2007).","journal-title":"Lancet Neurol"},{"issue":"10","key":"33904_CR2","doi-asserted-by":"publisher","first-page":"e0140765","DOI":"10.1371\/journal.pone.0140765","volume":"10","author":"Katharine J. Looker","year":"2015","unstructured":"Looker, K. J. et al. Global and Regional Estimates of Prevalent and Incident Herpes Simplex Virus Type 1 Infections in 2012. PLoS One 10 (2015).","journal-title":"PLOS ONE"},{"key":"33904_CR3","first-page":"428","volume":"26","author":"P Grout","year":"1976","unstructured":"Grout, P. & Barber, V. E. Cold sores-an epidemiological survey. J R Coll Gen Pract 26, 428\u2013434 (1976).","journal-title":"J R Coll Gen Pract"},{"key":"33904_CR4","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1001\/archophthalmol.2010.187","volume":"128","author":"RC Young","year":"2010","unstructured":"Young, R. C., Hodge, D. O., Liesegang, T. J. & Baratz, K. H. Incidence, recurrence, and outcomes of herpes simplex virus eye disease in Olmsted County, Minnesota, 1976\u20132007: the effect of oral antiviral prophylaxis. Arch Ophthalmol 128, 1178\u20131183 (2010).","journal-title":"Arch Ophthalmol"},{"key":"33904_CR5","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1126\/science.2434993","volume":"235","author":"JG Stevens","year":"1987","unstructured":"Stevens, J. G., Wagner, E. K., Devi-Rao, G. B., Cook, M. L. & Feldman, L. T. RNA complementary to a herpesvirus alpha gene mRNA is prominent in latently infected neurons. Science 235, 1056\u20131059 (1987).","journal-title":"Science"},{"key":"33904_CR6","doi-asserted-by":"crossref","first-page":"3841","DOI":"10.1128\/jvi.61.12.3841-3847.1987","volume":"61","author":"JG Spivack","year":"1987","unstructured":"Spivack, J. G. & Fraser, N. W. Detection of herpes simplex virus type 1 transcripts during latent infection in mice. J Virol 61, 3841\u20133847 (1987).","journal-title":"J Virol"},{"key":"33904_CR7","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1073\/pnas.88.3.790","volume":"88","author":"MJ Farrell","year":"1991","unstructured":"Farrell, M. J., Dobson, A. T. & Feldman, L. T. Herpes simplex virus latency-associated transcript is a stable intron. Proc Natl Acad Sci USA 88, 790\u2013794 (1991).","journal-title":"Proc Natl Acad Sci USA"},{"issue":"50","key":"33904_CR8","doi-asserted-by":"publisher","first-page":"6733","DOI":"10.1016\/j.vaccine.2014.10.002","volume":"32","author":"Tiffany Kuo","year":"2014","unstructured":"Kuo, T., Wang, C., Badakhshan, T., Chilukuri, S. & BenMohamed, L. The challenges and opportunities for the development of a T-cell epitope-based herpes simplex vaccine. Vaccine 32 (2014).","journal-title":"Vaccine"},{"key":"33904_CR9","doi-asserted-by":"crossref","first-page":"7405","DOI":"10.1016\/S0021-9258(18)83248-3","volume":"264","author":"JE Reardon","year":"1989","unstructured":"Reardon, J. E. & Spector, T. Herpes simplex virus type 1 DNA polymerase. Mechanism of inhibition by acyclovir triphosphate. J Biol Chem 264, 7405\u20137411 (1989).","journal-title":"J Biol Chem"},{"key":"33904_CR10","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1093\/ndt\/gfg119","volume":"18","author":"A Helld\u00e9n","year":"2003","unstructured":"Helld\u00e9n, A. et al. High serum concentrations of the acyclovir main metabolite 9-carboxymethoxymethylguanine in renal failure patients with acyclovir-related neuropsychiatric side effects: an observational study. Nephrol Dial Transplant 18, 1135\u20131141 (2003).","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"33904_CR11","doi-asserted-by":"publisher","first-page":"e941","DOI":"10.1097\/MJT.0000000000000093","volume":"23","author":"Mohammed Andaleeb Chowdhury","year":"2016","unstructured":"Chowdhury, M. A. et al. Acyclovir-Induced Neurotoxicity: A Case Report and Review of Literature. Am J Ther 23 (2016).","journal-title":"American Journal of Therapeutics"},{"key":"33904_CR12","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jcv.2004.04.002","volume":"32","author":"R Str\u00e1nsk\u00e1","year":"2005","unstructured":"Str\u00e1nsk\u00e1, R. et al. Survey of acyclovir-resistant herpes simplex virus in the Netherlands: prevalence and characterization. J Clin Virol 32, 7\u201318 (2005).","journal-title":"J Clin Virol"},{"key":"33904_CR13","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1086\/431585","volume":"41","author":"D Malvy","year":"2005","unstructured":"Malvy, D. et al. A retrospective, case-control study of acyclovir resistance in herpes simplex virus. Clin Infect Dis 41, 320\u2013326 (2005).","journal-title":"Clin Infect Dis"},{"key":"33904_CR14","first-page":"19","volume":"130B","author":"JJ Kim","year":"2004","unstructured":"Kim, J. J. et al. Exposure to cytomegalovirus and polymorphisms in two genes on chromosome 6p21-23 as joint risk factors for schizophrenia. American Journal of Medical Genetics 130B, 19 (2004).","journal-title":"American Journal of Medical Genetics"},{"key":"33904_CR15","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1055\/s-0029-1185340","volume":"75","author":"A Evidente","year":"2009","unstructured":"Evidente, A. et al. Biological evaluation of structurally diverse amaryllidaceae alkaloids and their synthetic derivatives: discovery of novel leads for anticancer drug design. Planta Med 75, 501\u2013507 (2009).","journal-title":"Planta Med"},{"key":"33904_CR16","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0923-2516(89)80089-5","volume":"140","author":"J Renard-Nozaki","year":"1989","unstructured":"Renard-Nozaki, J., Kim, T., Imakura, Y., Kihara, M. & Kobayashi, S. Effect of alkaloids isolated from Amaryllidaceae on herpes simplex virus. Res Virol 140, 115\u2013128 (1989).","journal-title":"Res Virol"},{"key":"33904_CR17","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1021\/np50089a003","volume":"55","author":"B Gabrielsen","year":"1992","unstructured":"Gabrielsen, B. et al. Antiviral (RNA) activity of selected Amaryllidaceae isoquinoline constituents and synthesis of related substances. J Nat Prod 55, 1569\u20131581 (1992).","journal-title":"J Nat Prod"},{"key":"33904_CR18","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1021\/acsmedchemlett.5b00318","volume":"7","author":"J McNulty","year":"2015","unstructured":"McNulty, J. et al. iPSC Neuronal Assay Identifies Amaryllidaceae Pharmacophore with Multiple Effects against Herpesvirus Infections. ACS Med Chem Lett 7, 46\u201350 (2015).","journal-title":"ACS Med Chem Lett"},{"key":"33904_CR19","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1093\/schbul\/sbu032","volume":"41","author":"L D\u2019Aiuto","year":"2015","unstructured":"D\u2019Aiuto, L. et al. Persistent Infection by HSV-1 Is Associated With Changes in Functional Architecture of iPSC-Derived Neurons and Brain Activation Patterns Underlying Working Memory Performance. Schizophr Bull 41, 123\u2013132 (2015).","journal-title":"Schizophr Bull"},{"key":"33904_CR20","first-page":"5895","volume":"1","author":"O Revu","year":"2016","unstructured":"Revu, O. et al. Total Synthesis of the Natural Product (+)-trans-Dihydronarciclasine via an Asymmetric Organocatalytic [3\u2009+\u20093]-Cycloaddition and discovery of its potent anti-Zika Virus (ZIKV) Activity. Chemisty Select 1, 5895\u20135899 (2016).","journal-title":"Chemisty Select"},{"key":"33904_CR21","doi-asserted-by":"publisher","first-page":"6817","DOI":"10.1128\/JVI.00166-07","volume":"81","author":"K Wang","year":"2007","unstructured":"Wang, K. et al. Diverse herpes simplex virus type 1 thymidine kinase mutants in individual human neurons and Ganglia. J Virol 81, 6817\u20136826 (2007).","journal-title":"J Virol"},{"key":"33904_CR22","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1128\/jvi.21.2.584-600.1977","volume":"21","author":"RW Honess","year":"1977","unstructured":"Honess, R. W. & Watson, D. H. Herpes simplex virus resistance and sensitivity to phosphonoacetic acid. J Virol 21, 584\u2013600 (1977).","journal-title":"J Virol"},{"key":"33904_CR23","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.antiviral.2017.03.016","volume":"142","author":"L D\u2019Aiuto","year":"2017","unstructured":"D\u2019Aiuto, L. et al. Comparison of three cell-based drug screening platforms for HSV-1 infection. Antiviral Res 142, 136\u2013140 (2017).","journal-title":"Antiviral Res"},{"key":"33904_CR24","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1128\/jvi.68.3.1271-1282.1994","volume":"68","author":"GB Devi-Rao","year":"1994","unstructured":"Devi-Rao, G. B., Bloom, D. C., Stevens, J. G. & Wagner, E. K. Herpes simplex virus type 1 DNA replication and gene expression during explant-induced reactivation of latently infected murine sensory ganglia. J Virol 68, 1271\u20131282 (1994).","journal-title":"J Virol"},{"key":"33904_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/CMR.17.1.1-13.2004","volume":"17","author":"DW Kimberlin","year":"2004","unstructured":"Kimberlin, D. W. Neonatal herpes simplex infection. Clin Microbiol Rev 17, 1\u201313 (2004).","journal-title":"Clin Microbiol Rev"},{"key":"33904_CR26","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.1471-0528.2010.02785.x","volume":"118","author":"C Gardella","year":"2011","unstructured":"Gardella, C. & Brown, Z. Prevention of neonatal herpes. BJOG 118, 187\u2013192 (2011).","journal-title":"BJOG"},{"key":"33904_CR27","doi-asserted-by":"publisher","first-page":"3054","DOI":"10.1038\/sj.onc.1210952","volume":"27","author":"R Tsuruma","year":"2008","unstructured":"Tsuruma, R. et al. Physical and functional interactions between STAT3 and KAP1. Oncogene 27, 3054\u20133059 (2008).","journal-title":"Oncogene"},{"key":"33904_CR28","doi-asserted-by":"publisher","first-page":"11347","DOI":"10.1128\/JVI.02008-15","volume":"89","author":"CA King","year":"2015","unstructured":"King, C. A., Li, X., Barbachano-Guerrero, A. & Bhaduri-McIntosh, S. STAT3 Regulates Lytic Activation of Kaposi\u2019s Sarcoma-Associated Herpesvirus. J Virol 89, 11347\u201311355 (2015).","journal-title":"J Virol"},{"key":"33904_CR29","doi-asserted-by":"publisher","first-page":"E1669","DOI":"10.1073\/pnas.1305475110","volume":"110","author":"M Shu","year":"2013","unstructured":"Shu, M., Taddeo, B., Zhang, W. & Roizman, B. Selective degradation of mRNAs by the HSV host shutoff RNase is regulated by the UL47 tegument protein. Proc Natl Acad Sci USA 110, E1669\u20131675 (2013).","journal-title":"Proc Natl Acad Sci USA"},{"key":"33904_CR30","doi-asserted-by":"publisher","first-page":"13569","DOI":"10.1128\/JVI.02603-13","volume":"87","author":"M Shu","year":"2013","unstructured":"Shu, M., Taddeo, B. & Roizman, B. The nuclear-cytoplasmic shuttling of virion host shutoff RNase is enabled by pUL47 and an embedded nuclear export signal and defines the sites of degradation of AU-rich and stable cellular mRNAs. J Virol 87, 13569\u201313578 (2013).","journal-title":"J Virol"},{"key":"33904_CR31","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1159\/000476034","volume":"3","author":"P Dimitrion","year":"2017","unstructured":"Dimitrion, P. et al. Low-Density Neuronal Cultures from Human Induced Pluripotent Stem Cells. Mol Neuropsychiatry 3, 28\u201336 (2017).","journal-title":"Mol Neuropsychiatry"},{"key":"33904_CR32","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1080\/15476278.2015.1011921","volume":"10","author":"L D\u2019Aiuto","year":"2014","unstructured":"D\u2019Aiuto, L. et al. Large-scale generation of human iPSC-derived neural stem cells\/early neural progenitor cells and their neuronal differentiation. Organogenesis 10, 365\u2013377 (2014).","journal-title":"Organogenesis"},{"key":"33904_CR33","doi-asserted-by":"publisher","first-page":"5251","DOI":"10.1128\/AAC.00417-09","volume":"53","author":"MN Prichard","year":"2009","unstructured":"Prichard, M. N. et al. Inhibition of herpesvirus replication by 5-substituted 4\u2032-thiopyrimidine nucleosides. Antimicrob Agents Chemother 53, 5251\u20135258 (2009).","journal-title":"Antimicrob Agents Chemother"},{"key":"33904_CR34","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/0166-3542(91)90068-3","volume":"15","author":"BE Korba","year":"1991","unstructured":"Korba, B. E. & Milman, G. A cell culture assay for compounds which inhibit hepatitis B virus replication. Antiviral Res 15, 217\u2013228 (1991).","journal-title":"Antiviral Res"},{"key":"33904_CR35","doi-asserted-by":"publisher","first-page":"8743","DOI":"10.1039\/C6OB01189F","volume":"14","author":"M Maiti","year":"2016","unstructured":"Maiti, M. et al. Bifunctional aryloxyphosphoramidate prodrugs of 2\u2032-C-Me-uridine: synthesis and anti-HCV activity. Org Biomol Chem 14, 8743\u20138757 (2016).","journal-title":"Org Biomol Chem"},{"key":"33904_CR36","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.virol.2008.05.034","volume":"378","author":"S Ramachandran","year":"2008","unstructured":"Ramachandran, S., Knickelbein, J. E., Ferko, C., Hendricks, R. L. & Kinchington, P. R. Development and pathogenic evaluation of recombinant herpes simplex virus type 1 expressing two fluorescent reporter genes from different lytic promoters. Virology 378, 254\u2013264 (2008).","journal-title":"Virology"},{"key":"33904_CR37","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.antiviral.2015.06.005","volume":"121","author":"L McClain","year":"2015","unstructured":"McClain, L. et al. Broad-spectrum non-nucleoside inhibitors of human herpesviruses. Antiviral Res 121, 16\u201323 (2015).","journal-title":"Antiviral Res"},{"key":"33904_CR38","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/30.10.e47","volume":"30","author":"RM Cawthon","year":"2002","unstructured":"Cawthon, R. M. Telomere measurement by quantitative PCR. Nucleic Acids Res 30, e47 (2002).","journal-title":"Nucleic Acids Res"},{"key":"33904_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/1746-4811-8-48","volume":"8","author":"X Lin","year":"2012","unstructured":"Lin, X., Tirichine, L. & Bowler, C. Protocol: Chromatin immunoprecipitation (ChIP) methodology to investigate histone modifications in two model diatom species. Plant Methods 8, 48 (2012).","journal-title":"Plant Methods"},{"key":"33904_CR40","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139\u2013140 (2010).","journal-title":"Bioinformatics"},{"key":"33904_CR41","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1093\/bioinformatics\/btt703","volume":"30","author":"A Kr\u00e4mer","year":"2014","unstructured":"Kr\u00e4mer, A., Green, J., Pollard, J. & Tugendreich, S. Causal analysis approaches in Ingenuity Pathway Analysis. Bioinformatics 30, 523\u2013530 (2014).","journal-title":"Bioinformatics"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-33904-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-33904-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-33904-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T11:34:31Z","timestamp":1671622471000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-33904-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,9]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["33904"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-33904-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2018,11,9]]},"assertion":[{"value":"16 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"16662"}}